FibroGen, Inc. (KYNB)
NASDAQ · Healthcare
FibroGen, Inc. Total Liabilities 2013–2025
FibroGen, Inc. annual/quarterly total liabilities history from 2014 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- FibroGen, Inc. total liabilities for the quarter ending December 31, 2025 were 115.1M, a 71.09% decrease year-over-year.
- FibroGen, Inc. total liabilities for 2025 were 115.1M, a 71.09% decrease from 2024.
- FibroGen, Inc. total liabilities for 2024 were 398.2M, a 32.02% decrease from 2023.
- FibroGen, Inc. total liabilities for 2023 were 585.7M, a 4.23% decrease from 2022.
- FibroGen, Inc. total liabilities for 2022 were 611.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| FibroGen, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $115 |
| 2024 | $398 |
| 2023 | $586 |
| 2022 | $612 |
| 2021 | $545 |
| 2020 | $385 |
| 2019 | $322 |
| 2018 | $352 |
| 2017 | $351 |
| 2016 | $294 |
| 2015 | $274 |
| 2014 | $243 |
| FibroGen, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $115 |
| 2024-12-31 | $398 |
| 2023-12-31 | $586 |
| 2022-12-31 | $612 |
| 2021-12-31 | $545 |
| 2020-12-31 | $385 |
| 2019-12-31 | $322 |
| 2018-12-31 | $352 |
| 2017-12-31 | $351 |
| 2016-12-31 | $294 |
| 2015-12-31 | $274 |
| 2014-12-31 | $243 |
FibroGen, Inc. Total Liabilities — FAQ
FibroGen, Inc. (KYNB) total liabilities over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KYNB's total liabilities history?
The chart and table above show FibroGen, Inc.'s total liabilities by year and by quarter, including the growth rate.